Literature DB >> 23146923

High alcohol consumption increases the risk of pancreatic stone formation and pancreatic atrophy in autoimmune pancreatitis.

Kenji Hirano1, Minoru Tada, Hiroyuki Isayama, Takeo Watanabe, Tomotaka Saito, Rie Uchino, Tsuyoshi Hamada, Koji Miyabayashi, Suguru Mizuno, Dai Mohri, Takashi Sasaki, Hirofumi Kogure, Natsuyo Yamamoto, Naoki Sasahira, Nobuo Toda, Naminatsu Takahara, Hiroshi Yagioka, Dai Akiyama, Yukiko Ito, Kazuhiko Koike.   

Abstract

OBJECTIVES: This study aimed to investigate risk factors for pancreatic stones and atrophy in autoimmune pancreatitis (AIP).
METHODS: Seventy-one patients with AIP observed for more than 1 year were enrolled. The frequency of pancreatic stone development and atrophy on computed tomography as well as their risk factors were examined.
RESULTS: Pancreatic stones and atrophy were observed in 13 and 43 patients, respectively. Alcohol consumption of greater than 50 g/d was the only significant risk factor for pancreatic atrophy in univariate analysis. Alcohol intake of greater than 50 g/d was observed in 6 of 13 patients with stones and 10 of 58 patients without stones (46% vs 17%, P = 0.059). Alcohol intake of greater than 50 g/d was observed in 14 of 43 patients with atrophy and 2 of 28 patients without atrophy (33% vs 7.1%, P = 0.018). In multivariate analysis, alcohol consumption was a significant risk factor both for pancreatic stone formation (odds ratio [OR], 7.47; P = 0.040) and atrophy (OR 6.24; P = 0.034). Higher age at onset was another significant risk factor for pancreatic atrophy (OR 1.07 per year; P = 0.029).
CONCLUSIONS: Alcohol consumption of greater than 50 g/d increases the risk of pancreatic stone development and atrophy in patients with AIP.

Entities:  

Mesh:

Year:  2013        PMID: 23146923     DOI: 10.1097/MPA.0b013e31826b3984

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  10 in total

1.  Insulin secretion improvement during steroid therapy for autoimmune pancreatitis according to the onset of diabetes mellitus.

Authors:  Kensaku Noguchi; Yousuke Nakai; Suguru Mizuno; Hiroyuki Isayama; Kenji Hirano; Sachiko Kanai; Tomoka Nakamura; Rie Uchino; Naminatsu Takahara; Hirofumi Kogure; Minoru Tada; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2019-08-30       Impact factor: 7.527

2.  Extracorporeal shock wave lithotripsy treatment of pancreatic stones complicated with advanced stage autoimmune pancreatitis.

Authors:  Masahiro Maruyama; Takayuki Watanabe; Keita Kanai; Takaya Oguchi; Jumpei Asano; Tetsuya Ito; Takashi Muraki; Hideaki Hamano; Norikazu Arakura; Takeshi Uehara; Shigeyuki Kawa
Journal:  BMC Gastroenterol       Date:  2015-03-10       Impact factor: 3.067

Review 3.  Autoimmune Pancreatitis.

Authors:  Binit Sureka; Archana Rastogi
Journal:  Pol J Radiol       Date:  2017-02-25

4.  Clinical significance of pancreatic calcifications: a 15-year single-center observational study.

Authors:  Wei Wang; Li Chai; Naiyi Zhu; Qingrou Wang; Yiran Zhou; Weimin Chai
Journal:  Eur J Med Res       Date:  2022-06-25       Impact factor: 4.981

5.  Factors affecting glycemic control in diabetes mellitus complicated by autoimmune pancreatitis.

Authors:  Nozomi Harai; Akihiro Nishimura; Kimio Matsumura; Yuya Suzuki; Shota Kikuno; Tetsuro Kobayashi; Kaoru Nagasawa; Yasumichi Mori
Journal:  J Diabetes Investig       Date:  2022-04-12       Impact factor: 3.681

6.  Type 1 autoimmune pancreatitis can transform into chronic pancreatitis: a long-term follow-up study of 73 Japanese patients.

Authors:  Masahiro Maruyama; Norikazu Arakura; Yayoi Ozaki; Takayuki Watanabe; Tetsuya Ito; Suguru Yoneda; Masafumi Maruyama; Takashi Muraki; Hideaki Hamano; Akihiro Matsumoto; Shigeyuki Kawa
Journal:  Int J Rheumatol       Date:  2013-05-16

7.  Autoimmune pancreatitis can develop into chronic pancreatitis.

Authors:  Masahiro Maruyama; Takayuki Watanabe; Keita Kanai; Takaya Oguchi; Jumpei Asano; Tetsuya Ito; Yayoi Ozaki; Takashi Muraki; Hideaki Hamano; Norikazu Arakura; Shigeyuki Kawa
Journal:  Orphanet J Rare Dis       Date:  2014-05-21       Impact factor: 4.123

8.  Early pancreatic volume reduction on CT predicts relapse in patients with type 1 autoimmune pancreatitis treated with steroids.

Authors:  Yoshinori Ohno; Teru Kumagi; Tomoyuki Yokota; Nobuaki Azemoto; Yoshinori Tanaka; Kazuhiro Tange; Nobu Inada; Hideki Miyata; Yoshiki Imamura; Mitsuhito Koizumi; Taira Kuroda; Yoichi Hiasa
Journal:  Orphanet J Rare Dis       Date:  2016-07-28       Impact factor: 4.123

Review 9.  Long-term outcomes of autoimmune pancreatitis.

Authors:  Tsukasa Ikeura; Hideaki Miyoshi; Masaaki Shimatani; Kazushige Uchida; Makoto Takaoka; Kazuichi Okazaki
Journal:  World J Gastroenterol       Date:  2016-09-14       Impact factor: 5.742

10.  Transpapillary biliary stenting is a risk factor for pancreatic stones in patients with autoimmune pancreatitis.

Authors:  Hiroyuki Matsubayashi; Yoshihiro Kishida; Tomohiro Iwai; Katsuyuki Murai; Masao Yoshida; Kenichiro Imai; Yusuke Yamamoto; Masataka Kikuyama; Hiroyuki Ono
Journal:  Endosc Int Open       Date:  2016-08-08
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.